Public private partnership in vascular surgery / Parceria público-privada em cirurgia vascular

Objective To describe and analyze the results of a public-private partnership between the Ministry of Health and a private hospital in a project of assistance and scientific research in the field of endovascular surgery. Methods: The flows, costs and clinical outcomes of patients treated in a the public-private partnership between April 2012 and July 2013 were analyzed. All patients underwent surgery and stayed at least one day at the intensive care unit of the private hospital. They also participated in a research protocol to compare two intravenous contrast media used in endovascular surgery (iodinated contrast and carbon dioxide). Results A total of 62 endovascular procedures were performed in 57 patients from the public healthcare system. Hospital and endovascular supplies expenses were significantly higher as compared to the amount paid by the Unified Health System (SUS - Sistema Único de Saúde) in two out of three disease groups studied. Among outpatients, the average interval between appointment and surgery was 15 days and, in hospitalized patients 7 days. All procedures were successful with no conversion to open surgery. The new contrast medium studied - carbon dioxide – was effective and cheaper. Conclusion The waiting time for patients between indication and accomplishment of surgery was significantly reduced. Public-private partnerships can speed up care of patients from public health services, and generate and improve scientific knowledge. .

Objetivo Descrever e analisar os resultados de parceria público-privada entre o Ministério da Saúde e um hospital privado em projeto de assistência e pesquisa científica na área de cirurgia endovascular. Métodos: Foram analisados fluxos, custos e resultados clínicos dos pacientes atendidos numa parceria público-privada entre abril de 2012 e julho de 2013. Todos os pacientes foram operados, ficaram pelo menos um dia na unidade de terapia intensiva do hospital privado e participaram de um protocolo de pesquisa para comparação entre dois contrastes endovenosos para cirurgia endovascular (contraste iodado e dióxido de carbono). Resultados Foram realizados 62 procedimentos endovasculares em 57 pacientes provenientes do sistema público. Os gastos hospitalares e com material endovascular mostraram-se significativamente maiores em relação ao que é pago pelo Sistema Único de Saúde (SUS) em dois dos três grupos de doenças estudados. Entre os pacientes ambulatoriais, o intervalo médio entre a consulta e a cirurgia foi de 15 dias e, nos internados, 7 dias. Todos os procedimentos foram bem sucedidos, sem conversão para cirurgia aberta. O novo contraste estudado, o dióxido de carbono, mostrou-se eficaz e mais barato. Conclusão O tempo de espera dos pacientes entre indicação cirúrgica e sua realização foi significativamente reduzido. Parcerias público-privadas podem trazer agilidade no atendimento dos pacientes do SUS, permitindo também geração de conhecimento científico. .

Comparison of Costs of Endovascular Repair versus Open Surgical Repair for Abdominal Aortic Aneurysm in Korea

This study was designed to compare the hospital-related costs of elective abdominal aortic aneurysm (AAA) treatment and cost structure between endovascular aneurysm repair (EVAR) and open surgical repair (OSR) in Korean health care system. One hundred five primary elective AAA repairs (79 OSRs and 26 EVARs) performed in the Seoul National University Hospital from 2005 to 2009 were included. Patient characteristics were similar between two groups except for older age (P = 0.004) and more frequent history of malignancy (P = 0.031) in EVAR group. Thirty-day mortality rate was similar between two groups and there was no AAA-related mortality in both groups for 5 yr after repair. The total in-hospital costs for the index admission were significantly higher in EVAR patients (mean, KRW19,857,119) than OSR patients (mean KRW12,395,507) (P < 0.001). The reimbursement was also significantly higher in EVAR patients than OSR patients (mean, KRW14,071,081 vs KRW6,238,895, P < 0.001) while patients payments was comparable between two groups. EVAR patients showed higher follow-up cost up to 2 yr due to more frequent imaging studies and reinterventions for type II endoleaks (15.4%). In the perspective of cost-effectiveness, this study suggests that the determination of which method to be used in AAA treatment be more finely trimmed and be individualized.

Altos custos financeiros do trauma vascular / Expensive therapy of vascular trauma

OBJETIVO: Demonstrar o custo e impacto financeiro referente à primeira abordagem cirúrgica das lesões vasculares em pacientes admitidos no Hospital João XXIII/FHEMIG, entre os anos de 2004 a 2006. MéTODOS: Trata-se de um estudo com aprovação ética, retrospectivo, de coorte e descritivo realizado a partir da auditoria de contas hospitalares referentes a 70 prontuários catalogados pelo Serviço de Trauma Cardiovascular. RESULTADOS: Cinco (7,14 por cento) prontuários foram excluídos por má qualidade técnica. O valor monetário repassado pelo Sistema Único de Saúde e pelo setor privado foram de R$ 103.614,96 (US$ 60.949,97) e de R$ 185.888,21 (US$ 109.346,0, respectivamente, implicando em defasagem potencial de 44 por cento. Houve correlação direta entre custos e topografia anatômica das lesões e exponencial em relação às variáveis hemoderivados e próteses vasculares. CONCLUSÃO: Este estudo corrobora os altos custos do trauma vascular e fortalece a importância da auditoria de contas para as tomadas de decisões médicas.

OBJECTIVE: To analyze all expenses paid to the first surgical approached for vascular lesion patients admitted at Hospital João XXIII/FHEMIG, between years 2004 until 2006. METHOD: It is about an ethical approved study, retrospective and descriptive from audit over 70 eligible patients enrolled by Cardiovascular Service. RESULTS: Five (7,14 percent) patient's files were excluded for bad quality records. The costs were R$ 103.614,96 (US$ 60.949,97) and R$ 185.888,21 (US$ 109.346,0), a 44 percent sliding scale for endowment from Brazilian Public System and private medical assistance estimative, respectively. Indeed, the data showed direct relationship between costs and anatomic topographic and exponential increased expenses when blood and/or vascular prosthesis were utilized. CONCLUSION: Audit in health system is a must to making decision and evidences the expensive therapy for vascular lesions.

Manejo del aneurisma de la aorta abdominal: Estado actual, evidencias y perspectivas para el desarrollo de un programa nacional / Open and endovascular surgery for the treatment of abdominal aortic aneurism: Review of the available evidence

Open and endovascular surgery are therapeutic alternatives for the treatment of abdominal aortic aneurism. The development of guidelines for its treatment requires a thorough analysis of available evidence to recommend the best treatment for each country's reality. Prospective randomized trials have shown best initial results with endovascular surgery, with higher hospital costs than open surgery. The requirement of anatomical suitability for the placement of endovascular prostheses limits the universal use of endovascular surgery. Moreover, this type of surgery needs a strict imaging and clinical follow up due to the high rates of late complications, which range from 20 percent to 40 percent. Many of these complications require further surgical interventions, elevating costs of treatment. The initial benefit of endovascular surgery is lost during long follow up as survival curves become similar to those of open surgery. Even for patients with a high surgical risk, the benefits of endovascular surgery are doubtful.